Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
53 /100
HIGH RISK
Score updated Oct 13, 2026

KAPA — Kairos Pharma, Ltd. Dilution Risk Tracker

Track KAPA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KAPA — Get alerts when the score changes →

As of October 13, 2026, Kairos Pharma, Ltd. (KAPA) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. Kairos Pharma, Ltd. has a market capitalization of $19.72M, 23.70M shares outstanding, 11 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $15.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
37
⚠️ Warrant Exposure
40
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 42%
🔄 Reverse Split model est. 65%
• 50-day avg $0.57 below $1 exchange minimum
• 9 months cash with weak price
💰 Capital Raise model 33%
• Under 12 months cash (9mo)
• Active ATM program with $15M remaining capacity
🔔 Track KAPA — Get forecast alerts →

Market Data

Market Cap$19.72M
Shares Outstanding23.70M
Float12.42M
Cash$2.63M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore53/100DilutionWatch score record
Shares Outstanding23.70MVerified float table or market cache
Public Float12.42MVerified float table or market cache
Market Cap$19.72MMarket data cache
Cash Runway9.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$15.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 424B3 2, 8-K 1, EFFECT 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 5.3% shares (2026Q1 vs prior)
11 institutional holders · 832.9K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 463.8K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 111.3K shares
#3 VANGUARD FIDUCIARY TRUST CO 63.9K shares
+ 8 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest113.2K
Days to Cover1.0
% of Float0.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2026-03-31
424B3 ATM 2026-04-01
424B3 ATM 2026-04-01
8-K 8K EVENT 2026-03-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KAPA Dilution Snapshot

Kairos Pharma, Ltd. (KAPA) has a DilutionScore of 53/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KAPA's DilutionScore is currently 53/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 57/100 (High risk).

Period Score Risk Level Duration
Oct 11 – Oct 13, 202653/100HIGH3 days
Aug 22 – Oct 10, 202657/100HIGH50 days
Aug 14 – Aug 21, 202649/100MEDIUM7 days
Jul 16 – Aug 13, 202661/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KAPA shares outstanding have decreased 0.0% from 21.41M (Apr 2026) to 21.41M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 11, 202621.41M12.42M▲ 2.09%
Apr 03, 202621.41M12.17M▲ 2.83%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KAPA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KAPA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KAPA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KAPA
KAPA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.